Driving or operating machinery
If you experience unwanted effects, including dizziness or blurred
Articaine hydrochloride 4% with adrenaline
vision, you should not drive or operate machinery until these effects
(epinephrine) injection 1:100,000
How this medicine will be used
Your dentist will explain to you why you are being treated withSEPTANEST and tell you which formula and what dose you will be
Articaine hydrochloride 4% with adrenaline
administered. One cartridge is usually sufficient but your dentist maygive you a greater quantity. He chooses the formula and adjusts the
(epinephrine) injection 1:200,000
dosage according to your age, to your health and to the dental work.
SEPTANEST 1:200,000 is usually used for simple and short dental works.
SEPTANEST 1:100,000 is more adapted to procedures lasting longer or
PATIENT INFORMATION LEAFLET
Please read this leaflet carefully before you start using this
What to do if an overdose is taken
medicine. It tells you the important points you should knowabout SEPTANEST.
If you think you may have been given too much of this injection and feel
What's in your medicine
SEPTANEST like most other medicines, may cause side effects insome patients. Although not all of these side effects may occur, if they
Each ml of solution for injection contains 40.00 mg of articaine
do occur they may need medical attention. While you are in your dentist
office, your dentist will carefully follow the effects of SEPTANEST.
- 18.2 micrograms of adrenaline (epinephrine) as the acid tartrate
However, some effects may not be noticed or appear later. Check with your
(10.00 micrograms expressed as base) for SEPTANEST 1:100,000.
dentist, doctor or pharmacist if any of the following side effects occur :
- 9.1 micrograms of adrenaline (epinephrine) as the acid tartrate (5.00
- you are feeling nervous, nauseous or dizzy,
micrograms expressed as base) for SEPTANEST 1:200,000.
It is a clear and colourless solution.
- you are trembling, have buzzing in the ears, blurred vision or have
It also includes the following inactive ingredients: sodium metabisulphite,
any abnormal feeling, yawning, problems with speech, shaking,
sodium chloride, sodium hydroxide and water for injections.
SEPTANEST is available in boxes containing 50 cartridges of 1.7 ml or of 2.2 ml.
- your heart is beating slowly or irregularly,- you have facial swelling or inflammation of gums,
Name of marketing authorisation holder: Septodont UK Ltd, Units R & S
- you have skin rash, hives or itching or severe allergic reaction,
- Orchard Business Centre - St Barnabas Close -Allington, Maidstone, Kent
- you may have a loss of sensation and muscle function following the
injection of SEPTANEST. Resolution occurs generally within eight weeks.
Name of manufacturer: Septodont, 58 rue du Pont de Créteil, 94100
You may be hypersensitive to sulphites and therefore show allergic
symptoms to SEPTANEST as respiratory or skin reactions.
About your medicine
If you have problems with the blood supply to your arms and/or legs orhigh blood pressure this medicine may result in a small injury at the site
SEPTANEST is given by injection to cause loss of feeling before and
during dental procedures. It contains two active ingredients: articaine
Patients who already have a condition of the blood called
hydrochloride, a local anaesthetic which prevents pain, and adrenaline
methaemoglobinaemia may find they become worse.
tartrate, a vasoconstrictor which makes the effect last longer(Adrenaline narrows the blood vessels at the site of injection, which
keeps the anaesthetic where needed for a longer time) and controls the
Your dentist will not use this medicine if its colour is pinkish or darker
than slightly yellow of if it contains a precipitate.
Before this medicine is used
SEPTANEST 1:100,000 and 1:200,000 contain less than 1 mmolsodium (0.058 mmol/ 1.7 ml or 0.075 mmol/ 2.2 ml), i.e. essentially
SEPTANEST is not for use in children of less than 4 years.
SEPTANEST contains sodium metabisulphite (E 223). Sodium
Storing your medicine
metabisulphite can cause allergic-type reactions including anaphylacticsymptoms and bronchospasm (difficulty in breathing) in some people. If
It is most unlikely that you will be asked to look after this medicine. Your
you suffer from allergy or asthma this is more likely to happen.
dentist will keep it up to 25° C, stored in the original container (protected
Before receiving this medicine, tell your dentist if:
from light). It should not be frozen. He will not use this medicine after
- you are allergic to local anaesthetics or any particular ingredients,
the expiry date printed on the package.
- you are asthmatic or have suffered difficulty with your breathing as a
All medicines must be kept in a safe place out of the reach of children.
result of taking medicines which contain ingredients called sulphites
- you are taking antidepressant treatment or have taken such a drug
Remember this medicine is only for you. Only a dentist can administer
- you have problems in the way your muscles work by not having
This leaflet provides only a summary of the information
enough of a substance called cholinesterase in your body,
known about SEPTANEST. If you have any questions,
- you have problems with your heart, your blood vessels, your heart
want to know more about this medicine, or have some
Date of preparation: September 2004.
If more PILs are necessary, call free number 0800
- you have diabetes or have an overactive thyroid gland, whether or not
There are medicines which should not be given with SEPTANEST or whichshould be used with caution as ß-blocking agents (e.g. propranolol), cardiac
glycosides (e.g. digoxin) and vasopressor drugs (e.g. dihydroergotamine).
Please make sure that you tell your dentist about all medicines which you
are taking, whether prescribed or purchased.
58, rue du Pont de Créteil.
94100 Saint-Maur-des-Fossés, France.
PRISE EN CHARGE DES NAUSEES ET VOMISSEMENTS POST-OPERATOIRES Validation par Dr E. AHLSCHWEDE Dr. MOULLIER chef de service d’anesthésie M. LAURENCIN président COMEDIMS DIFFUSION: services de chirurgie et de gynécologie – obstétrique, service d’anesthésie 1. OBJECTIFS : Traitement et prophylaxie des nausées et vomissements post-opératoires (NVPO).
Review of Services for Alabama Girls Charged with Delinquency Marty Beyer, Ph.D. and Paul DeMuro AlAbAmA DisAbility ADvocAcy ProgrAm center for Public rePresentAtion southern Poverty lAw center EXECUTIVE SUMMARY Alabama has made excellent progress in reaching a primary goal of the 2008 Juvenile Justice Act (Act) — to promote community-based alternatives to costly institutional settings w